How safe are anticholinergics in patients with COPD?

Med J Aust. 2009 May 4;190(9):468-9. doi: 10.5694/j.1326-5377.2009.tb02519.x.

Abstract

Guidance for clinicians on how to interpret conflicting evidence from recent studies.

Publication types

  • Editorial

MeSH terms

  • Cardiovascular Diseases / epidemiology
  • Cholinergic Antagonists / administration & dosage
  • Cholinergic Antagonists / adverse effects*
  • Humans
  • Ipratropium / administration & dosage
  • Ipratropium / adverse effects*
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Pulmonary Disease, Chronic Obstructive / epidemiology
  • Research Design
  • Scopolamine Derivatives / administration & dosage
  • Scopolamine Derivatives / adverse effects*
  • Tiotropium Bromide

Substances

  • Cholinergic Antagonists
  • Scopolamine Derivatives
  • Ipratropium
  • Tiotropium Bromide